Nektar Therapeutics (NKTR)
70.62
-3.71
(-4.99%)
USD |
NASDAQ |
May 15, 16:00
70.70
+0.08
(+0.11%)
After-Hours: 20:00
Nektar Therapeutics Total Assets (Quarterly) : 763.27M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 116.58B |
| Aquestive Therapeutics, Inc. | 141.12M |
| Boston Scientific Corp. | 44.35B |
| Esperion Therapeutics, Inc. | 462.53M |
| Corcept Therapeutics, Inc. | 814.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 187.06M |
| Shareholders Equity (Quarterly) | 576.22M |
| Debt to Equity Ratio | 0.2489 |
| Current Ratio | 10.21 |
| Net Debt Paydown Yield | 0.82% |